author-photo

Nicholas Murray

Southampton General Hospital

8

Papers

54

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (37)
Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Abstract PD07-09: Zoledronate versus ibandronate comparative evaluation (ZICE) trial - first results of a UK NCRI 1,405 patient phase III trial comparing oral ibandronate versus intravenous zoledronate in the treatment of breast cancer patients with bone metastases.

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
200 TACT2 Trial in Early Breast Cancer (EBC): Differential Rates of Amenorrhoea in Premenopausal Women Following Adjuvant Epirubicin (E) or Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF (CRUK/05/019)

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Interim safety data on the ZICE trial: A randomized phase III, open-label, multicener, parallel group clinical trial to evaluate and compare the efficacy, safety profile, and tolerability of oral ibandronate versus intravenous zoledronate in the treatment of patients with breast cancer with bone metastases.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-10-06: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) in 129 UK Hospitals (4391 Patients) (CRUK/05/019)

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)